Recruiting PHASE2 INTERVENTIONAL 2-arm NCT06421597

Identifying Individuals At Risk of Glucocorticoid-Induced Impairment of Bone Disease (RIGID)

Sponsor: Esbjerg Hospital - University Hospital of Southern Denmark

Updated 6 times since 2024 Last updated: Nov 27, 2024 Started: Nov 4, 2024 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Osteoporosis Secondary, this trial is actively recruiting participants. The trial is conducted by Esbjerg Hospital - University Hospital of Southern Denmark and has accumulated 6 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Dec 2024 — Present [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Oct 2024 — Dec 2024 [monthly]

Not Yet Recruiting PHASE2
Sep 2024 — Oct 2024 [monthly]

Not Yet Recruiting PHASE2
Aug 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE2
Jul 2024 — Aug 2024 [monthly]

Not Yet Recruiting PHASE2

▶ Show 1 earlier version

Jun 2024 — Jul 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Esbjerg Hospital - University Hospital of Southern Denmark
Odense University Hospital
University of Birmingham
University of Ulm

Data source: Odense University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Esbjerg, Denmark
• Odense C, Denmark